Evidence map›Paper›PMID 40041890›Full record

ArticleActa pharmaceutica Sinica. B2025

Facilitation of mucosal healing by estrogen receptor

Yilei Guo, Yanrong Zhu, Jing Zhang, Yue He, Mianjiang Zhao, Haochang Lin, Zhifeng Wei, Yufeng Xia, Yue Dai

Abstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Kushenol I combats ulcerative colitisWorld journal of gastroenterology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yilei GuoDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
Yanrong ZhuDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
Jing ZhangDepartment of Pharmacognosy, China Pharmaceutical University, Nanjing 211198, China.
Yue HeDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
Mianjiang ZhaoDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
Haochang LinDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
Zhifeng WeiDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
Yufeng XiaDepartment of Pharmacognosy, China Pharmaceutical University, Nanjing 211198, China.
Yue DaiDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colonic mucosal healing is the ultimate goal of ulcerative colitis (UC) treatment, but it remains difficult to realize. Given the higher incidence of UC in males and the beneficial effect of estrogen on UC, we conducted this study to examine the therapeutic potential of estrogen receptor

Indexed as

AutophagyBranched-chain amino acids transportCell migrationEstrogen receptor βFocal adhesion kinaseLarge neutral amino acid transporter 1Mucosal healingUlcerative colitis

Identifiers

PMID40041890
PMCPMC11873653

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.